Healthcare -
Biotechnology - NASDAQ - US
$ 3.53
-0.843 %
$ 32.6 M
Market Cap
-0.56
P/E
Price Target
Average
75.64%
Revenue Forecast
Estimate
--3.69%
EBIT
Estimate
69.60%
Net Income
Estimate
34.37%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
SAB Biotherapeutics, Inc.
Wall Street analysts predict an average 1-year price target for SABS of $6.2 , with forecasts ranging from
a
low of
$3 to a high of $8 .
SABS Lowest Price Target
Wall Street Target
3 USD
-15.01%
SABS Average Price Target
Wall Street Target
6.2 USD
75.64%
SABS Highest Price Target
Wall Street Target
8 USD
126.63%
REVENUE FORECAST
Revenue Forecast Chart SABS
EBIT FORECAST
EBIT Forecast Chart SABS
NET INCOME FORECAST
Net Income Chart SABS